Access Statistics for Bruno Versaevel

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 6 18
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 5 33
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 9 25
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 1 10 20
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 3 8 22
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 1 3 15
Approche économique des accords de report d’entrée dans l’industrie pharmaceutique 0 0 0 0 1 1 4 5
Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 0 0 16 21
Better than a compromise, a third way: patent pool to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 0 0 8 15
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 0 13 2 3 25 47
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 0 0 0 0 8 14
Caveat Preemptor: Coordination Failure and Success in a Duopoly Investment Game 0 0 0 0 0 0 6 43
Conflict and Cooperation on R&D Markets 0 0 0 90 0 1 11 295
Coordination and Cooperation in Investment Timing with Externalities? 0 0 0 17 1 1 13 117
Covid-19: Should intellectual property rights be challenged? 0 0 0 8 0 0 3 79
Dynamic competition and intellectual property rights in a model of product development 0 0 0 0 0 0 1 19
Dynamic competition and intellectual property rights in a model of product development 0 0 0 1 0 0 7 45
Dynamique des marchés et ajustement de la protection Intellectuelle 0 0 0 0 0 0 4 19
Dynamique des marchés et ajustement de la protection intellectuelle 0 0 0 0 0 0 3 12
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 0 0 3 21
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 1 1 2 11
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 1 1 6 34
From Private to Public Common Agency 0 0 0 0 0 0 10 51
From private to public common agency 0 0 0 0 0 0 10 19
Horizontal R&D Cooperation and Spillovers: Evidence from France 0 0 0 0 0 1 7 15
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 1 2 7 23
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 1 12 43
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 0 13 44
Innovation and imitation incentives in dynamic duopoly 0 0 0 49 2 3 13 109
Investment Timing and Vertical Relationships 0 0 0 37 0 0 8 98
Investment timing and vertical relationships 0 0 0 0 0 0 7 15
Market Share, R&D Cooperation, and EU Competition Policy 0 0 0 3 0 0 11 39
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 0 0 3 36
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 0 0 13 28
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 0 0 6 9
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 0 0 5 19
On the Optimal Timing of Innovation and Imitation 0 0 0 0 0 1 6 22
On the Timing of Vertical Relationships 0 0 0 45 0 0 8 90
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 0 0 1 2 11 21
On the timing of innovation and imitation 0 0 0 28 0 1 10 53
On the timing of innovation and imitation in dynamic duopoly 0 0 0 0 0 0 4 14
On the timing of vertical relationships 0 0 0 36 2 2 14 84
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 0 28 0 1 15 75
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 0 0 1 3 15 45
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 1 12 23
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 10 10 24 37
Optimal Collusion with Limited Liability 0 0 0 0 1 1 9 44
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 0 1 1 7 29
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 52 0 3 13 132
Optimal collusion with limited liability 0 0 0 40 0 1 15 104
Patent Pools and Dynamic R&D Incentives 0 0 0 0 2 2 10 32
Patent Pools and R&D Dynamics 0 0 0 0 0 0 7 32
Patent pools and dynamic R&D incentives 0 0 0 0 0 0 9 51
Pool patents to get COVID vaccines and drugs to all 0 0 0 7 0 0 4 37
Quel rôle pour la part de marché quand le droit de la concurrence porte son regard sur la coopération et l'innovation 0 0 0 0 1 1 5 16
Quel rôle pour un critère de part de marché dans la réglementation de la coopération en recherche et développement ? 0 0 0 0 0 1 5 14
Quelles spécificités des accords de distribution en ligne ? 0 0 0 0 0 0 5 14
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 0 0 11 12
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 0 0 13 25
Tacit Collusion in Investment Timing 0 0 0 0 1 1 3 19
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 0 1 19 270
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 0 0 11 256
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 32 1 1 7 140
Timing Vertical Relationships 0 0 0 0 0 0 5 21
Timing Vertical Relationships 0 0 0 0 0 0 7 31
Timing Vertical Relationships 0 0 0 53 0 1 8 80
Timing Vertical Relationships 0 0 0 0 1 1 5 27
Timing Vertical Relationships 0 0 0 0 0 0 6 26
Timing Vertical Relationships 0 0 0 0 0 0 8 33
When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly 0 0 0 77 0 1 13 69
Total Working Papers 0 0 0 712 34 57 610 3,456
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 2 0 0 15 54
Caveat preemptor: Coordination failure and success in a duopoly investment game 0 0 0 11 0 0 8 116
Co-ordination costs and vertical integration in production franchise networks: a common agency model 0 0 0 46 1 1 8 145
Dynamic competition and intellectual property rights in a model of product development 0 1 1 8 1 3 17 97
From private to public common agency 0 0 0 29 0 0 12 130
Horizontal R and D cooperation and spillovers: evidence from France 0 0 0 5 0 0 11 53
Investment timing and vertical relationships 0 0 1 17 0 2 15 63
La spéculation sur le marché des actions: un phénomène monétaire ? 0 0 0 1 0 1 2 21
Market shares, R&D agreements, and the EU block exemption 0 0 1 12 0 0 13 94
Mieux qu’un compromis, une troisième voie: le panier de brevets pour accélérer l’accès aux vaccins et traitements contre la COVID-19 0 0 0 5 0 0 13 25
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 1 13 0 1 8 86
One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 2 0 0 18 64
Optimal collusion with limited liability 0 0 0 9 1 1 15 80
Patent pools and dynamic R&D incentives 0 0 0 27 2 2 20 135
Pool patents to get COVID vaccines and drugs to all 0 0 0 3 0 1 11 22
R&D Delegation in a Duopoly with Spillovers 0 0 0 26 0 1 8 117
Total Journal Articles 0 1 4 216 5 13 194 1,302


Statistics updated 2026-09-10